# Medeon Biodesign sells large bore vascular closure system to Terumo

Medeon Biodesign entered into a definitive asset purchase agreement with Terumo Corporation for its large bore vascular closure system (XPro System). The deal includes an upfront payment of US$20 million plus milestone payments.

- Type: Acquisition
- Announced: 2018-03-05
- Where: TWN
- Value: $20.0M
- Status: announced
- Products: large bore vascular closure system (XPro System)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md) (acquirer)
- [Medeon Biodesign](https://endata.com/companies/30475.md) (target)

## Sources

- [en.prnasia.com](https://en.prnasia.com/releases/global/medeon-entering-asset-purchase-agreement-with-terumo-for-its-large-bore-vascular-closure-system-203668.shtml), 2018-03-05: "Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce today that it entered into a definitive asset purchase agreement with Tokyo-based Terumo Corporation (TSE: 4543) for its large bore vascular closure system."
- [massdevice.com](https://www.massdevice.com/terumo-pays-least-20m-medeon-biodesigns-xpro-vascular-closure-device/), 2018-03-05: "We are pleased that the closure system's unique and innovative technology complements Terumo's vascular closure device portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.